Building on existing research, this study hypothesizes that ganodermanontriol can effectively alleviate pathological changes and inflammatory responses associated with acute pneumonia by modulating the phosphorylation and activation of the TNF/NF‐κB/MAPK signaling pathways. The gene discussed is NFKB1; the disease is pneumonia.